| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/18/2005 | US20050180969 which binds to B lymphoblastoid cells and induces proliferation and activation of peripheral blood lymphocytes; anti-tumor effect when injected into a tumor-bearing subject |
| 08/18/2005 | US20050180967 Polyclonal antibody composition for treating allergy |
| 08/18/2005 | US20050180960 producer cell (encapsulated in a matrix containing immunostimulating alginates) expresses a molecule that is an inhibitor of the growth of a CNS tumor |
| 08/18/2005 | US20050180947 Novel application of vaccination against TNF-alpha |
| 08/18/2005 | DE102004004787A1 New effector-linker and effector-recognition unit conjugates derived from epothilones, useful as targeted drugs for treating proliferative diseases, e.g. tumors or neurodegenerative disease |
| 08/18/2005 | CA2555306A1 Humanized antibody |
| 08/18/2005 | CA2555018A1 Treatment of conditions involving dopaminergic neuronal degeneration using nogo receptor antagonists |
| 08/18/2005 | CA2554880A1 Methods and compositions for modulating angiogenesis |
| 08/18/2005 | CA2554779A1 Compositions and methods for characterizing, regulating, diagnosing, and treating cancer |
| 08/18/2005 | CA2554628A1 Methods of modulating cd200 and cd200r |
| 08/18/2005 | CA2553679A1 Hmgb1 protein inhibitors for the regulation of smooth muscle cells and endothelial cells profileration |
| 08/18/2005 | CA2552999A1 Identification of novel ige epitopes |
| 08/17/2005 | EP1564286A1 Hybrid proteins of beta-lactamase class A |
| 08/17/2005 | EP1564285A1 Method of obtaining cell lines in a protein-free medium and cell lines thus obtained |
| 08/17/2005 | EP1563308A2 Methods and kits for diagnosing tumorigenicity |
| 08/17/2005 | EP1563298A2 Methods of isolation of active compounds and activated targets |
| 08/17/2005 | EP1563297A2 Method of inhibiting atherosclerotic plaque destabilization |
| 08/17/2005 | EP1563084A2 Transgenic ungulates having reduced prion protein activity and uses thereof |
| 08/17/2005 | EP1563071A2 Protein specific to pancreatic beta cells in islets of langerhans and applications thereof |
| 08/17/2005 | EP1563068A2 Genetic products differentially expressed in tumors and the use thereof |
| 08/17/2005 | EP1563062A1 Antimicrobial activity of antibodies producing reactive oxygen species |
| 08/17/2005 | EP1562990A2 Polyclonal-monoclonal elisa assay for detecting n-terminus probnp |
| 08/17/2005 | EP1562989A1 Monoclonal antibodies against n-terminus probnp |
| 08/17/2005 | EP1562985A2 Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases |
| 08/17/2005 | EP1562972A2 ALTERATION OF FcRn BINDING AFFINITIES OR SERUM HALF-LIVES OF ANTIBODIES BY MUTAGENESIS |
| 08/17/2005 | EP1562969A2 Novel human cell surface protein with immunoglobulin folds, bgs-19 |
| 08/17/2005 | EP1562968A1 Anti-il-6 antibodies, compositions, methods and uses |
| 08/17/2005 | EP1562967A2 Adipocyte complement related protein zacrp14 |
| 08/17/2005 | EP1562641A2 Ethylenedicysteine (ec)-drug conjugates, compositions and methods for tissue specific disease imaging |
| 08/17/2005 | EP1562632A2 Inducible ligand for alpha1 beta1 integrin and uses |
| 08/17/2005 | EP1562628A1 Dc-sign blockers and their use for preventing or treating viral infections. |
| 08/17/2005 | EP1562620A2 Modified cytokines for use in cancer therapy |
| 08/17/2005 | EP1562587A2 Novel compositions and methods for the treatment of immune related diseases |
| 08/17/2005 | EP1562571A1 Combination of diamide derivatives and immunosuppressive agents for induction of immune tolerance |
| 08/17/2005 | EP1345495A4 Methods for generating genetically altered antibody-producing cell lines with improved antibody characteristics |
| 08/17/2005 | EP1073723B1 Ste20-related protein kinases |
| 08/17/2005 | EP1051500B1 Diagnosis and treatment of aur1 and/or aur2 related disorders |
| 08/17/2005 | EP1023445B1 Cadherin derived growth factor and the application thereof |
| 08/17/2005 | EP0984983B1 Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and a kinase domain |
| 08/17/2005 | EP0975674B1 Immunotoxins, comprising an onc protein, directed against malignant cells |
| 08/17/2005 | EP0972201B1 Compounds for immunodiagnosis of prostate cancer and methods for their use |
| 08/17/2005 | EP0939804B1 NEUTROKINE alpha |
| 08/17/2005 | EP0833917B1 Malarial pre-erythrocytic stage polypeptide molecules |
| 08/17/2005 | EP0832189B1 Process for controlling sialylation of proteins produced by mammalian cell culture |
| 08/17/2005 | CN1656231A Method of analyzing non-complexed forms of prostate specific antigen in a sample to improve prostate cancer detection |
| 08/17/2005 | CN1656122A Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 08/17/2005 | CN1656121A Humanized antibody and process for preparing same |
| 08/17/2005 | CN1656120A Immunological binding molecules inhibiting the syncytial fusion of trophoblast |
| 08/17/2005 | CN1656116A Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the HPV-16 virus |
| 08/17/2005 | CN1656114A Novel pancortin-pablo protein interactions and methods of use thereof |
| 08/17/2005 | CN1655814A Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 08/17/2005 | CN1654661A Construction and expression of recombinant human trypsinogen 2 expression vector, preparation and application of its monoclonal antibody |
| 08/17/2005 | CN1654654A Heavy chain and light chain variable region gene of human B lymphocyte stimulation factor monoclonal antibody and its application |
| 08/17/2005 | CN1654639A Recombinant asparaginase with function of preventing and curing diabetes mellitus |
| 08/17/2005 | CN1654475A Preparation and use of conservative region of recombinant helicobacter pylori adhesin |
| 08/17/2005 | CN1654474A 重组幽门螺杆菌热休克蛋白60 Recombinant H. pylori heat shock protein 60 |
| 08/17/2005 | CN1654473A 重组幽门螺杆菌过氧化氢酶 Recombinant H. pylori catalase |
| 08/17/2005 | CN1654472A Recombinant helicobacter pylori outer-membrane protein 25 |
| 08/17/2005 | CN1654471A Recombinant helicobacter pylori blood group antigen adhesin |
| 08/17/2005 | CN1654470A Recombinant helicobacter pylori outer-membrane protein 15 |
| 08/17/2005 | CN1215167C Helicobacter pylori live vaccine |
| 08/17/2005 | CN1215083C Monoclonal antibody for resisting human liver cancer and its application |
| 08/17/2005 | CN1214817C Coupling factor 6 inhibitor and potentiator and use thereof |
| 08/17/2005 | CN1214816C Process and materials for the rapid detection of i(streptococcus pneumoniae) employing purified antigen-specific antibodies |
| 08/16/2005 | US6930181 a neuroendocrine protein antigen associated with Type I diabetes mellitus, nucleic acid encoding the protein and methods and reagents for detecting antibody against the protein and identifying individuals at risk of developing Type I diabetes |
| 08/16/2005 | US6930176 Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus |
| 08/16/2005 | US6930174 CCR5 chemokine receptor-specific antibodies |
| 08/16/2005 | US6930172 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/16/2005 | US6929955 Interactive system for presenting and eliminating substances |
| 08/16/2005 | US6929938 25501, a human transferase family member and uses therefor |
| 08/16/2005 | US6929930 Nucleotide sequences coding antigenic peptide for use in diagnosis of bacterial infections |
| 08/16/2005 | US6929924 eliminates all interference due to proinsulin and its intermediates, in particular des-31,32-proinsulin and/or des-64,65-proinsulin |
| 08/16/2005 | US6929907 Used for detecting incomplete deprotection of a synthetic oligonucleotide by immunoassay |
| 08/16/2005 | US6929791 An antibody which binds to an interleukin-2 (IL-2) peptide of given amino acid sequence; vectors |
| 08/16/2005 | CA2223642C Differential assay for ulcerative colitis, primary sclerosing cholangitis and type 1 autoimmune hepatitis |
| 08/16/2005 | CA2157500C Lo-cd2a antibody and uses thereof for inhibiting t-cell activation and proliferation |
| 08/16/2005 | CA2141025C Anti-mucus glycoprotein monoclonal antibody |
| 08/16/2005 | CA2086936C Method for producing members of specific binding pairs |
| 08/16/2005 | CA2084075C The ciliary neurotrophic factor receptor |
| 08/11/2005 | WO2005073732A2 Lc/ms method of analyzing high molecular weight proteins |
| 08/11/2005 | WO2005073727A1 Improved method for diagnosing acute coronary syndrome |
| 08/11/2005 | WO2005073394A1 Method of quickly measuring factor causing early flocculation of yeast |
| 08/11/2005 | WO2005073391A1 Factors causing early flocculation of yeast, antibodies thereto and utilization of the same |
| 08/11/2005 | WO2005073385A1 Composition and method for elevating gene transfer efficiency |
| 08/11/2005 | WO2005073383A2 HETERODIMERIC FOLLICLE STIMULATING HORMONE-Fc (FSH-Fc) FUSION PROTEINS FOR THE TREATMENT OF INFERTILITY |
| 08/11/2005 | WO2005073254A2 Methods for inhibiting squamous cell carcinoma using antibodies against laminin |
| 08/11/2005 | WO2005073253A1 Antibody inhibiting uracil-dna-glycosylase and uses thereof for decontaminating nucleic acid amplification reactions |
| 08/11/2005 | WO2005073252A1 Process for the manufacture of virus safe immunoglobulin |
| 08/11/2005 | WO2005072777A2 Conjugates of amyloid proteins as vaccines for amyloid-related diseases |
| 08/11/2005 | WO2005072772A1 Pharmaceutical compositions |
| 08/11/2005 | WO2005072479A2 Polymer-bound antibody concer therapeutic agent |
| 08/11/2005 | WO2005072457A2 Humoral response to hip1 in cancer |
| 08/11/2005 | WO2005072388A2 Osteoblast factor(s) that regulates human prostate cancer migration to and invasion of bone |
| 08/11/2005 | WO2005072385A2 Pituitary adenylate cyclase activating peptide (pacap) receptor (vpac2) agonists and their pharmacological methods of use |
| 08/11/2005 | WO2005072241A2 Inhibition of bright function as a treatment for excessive immunoglobulin production |
| 08/11/2005 | WO2005072129A2 Production of host cells containing mutiple integrating vectors by serial transduction |
| 08/11/2005 | WO2005072126A2 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 08/11/2005 | WO2005072112A2 Methods for producing and identifying multispecific antibodies |
| 08/11/2005 | WO2005072057A2 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases |
| 08/11/2005 | WO2005044854A3 Antagonist anti-cd40 monoclonal antibodies and methods for their use |